Skip to main content

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

TXG holding history

10x Genomics, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXG overviewAll 13F holders of TXGFull Q2 2026 holdings

Shares (Q2 2026)
261,470
Value
$10.0M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of TXG by Bellevue Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026261,470$10.0M0.2%−68,022−20.6%ReducedHolders
Q1 2026329,492$7.00M0.2%+7,432+2.3%AddedHolders
Q4 2025322,060$5.25M0.1%+8,224+2.6%AddedHolders
Q3 2025313,836$3.67M0.1%−12,915−4.0%ReducedHolders
Q2 2025326,751$3.78M0.1%+95,754+41.5%AddedHolders
Q1 2025230,997$2.02M<0.1%−39,731−14.7%ReducedHolders
Q4 2024270,728$3.89M0.1%−11,153−4.0%ReducedHolders
Q3 2024281,881$6.36M0.1%−26,430−8.6%ReducedHolders
Q2 2024308,311$6.00M0.1%00.0%UnchangedHolders
Q1 2024308,311$11.6M0.2%+15,138+5.2%AddedHolders
Q4 2023293,173$16.4M0.3%−1,259−0.4%ReducedHolders
Q3 2023294,432$12.1M0.2%−30,314−9.3%ReducedHolders
Q2 2023324,746$18.1M0.3%00.0%UnchangedHolders
Q1 2023324,746$18.1M0.3%00.0%UnchangedHolders
Q4 2022324,746$11.8M0.2%+70,612+27.8%AddedHolders
Q3 2022254,134$7.24M0.1%−5,237−2.0%ReducedHolders
Q2 2022259,371$11.7M0.2%+6,512+2.6%AddedHolders
Q1 2022252,859$19.2M0.2%+20,187+8.7%AddedHolders
Q4 2021232,672$34.7M0.4%00.0%UnchangedHolders
Q3 2021232,672$33.9M0.3%00.0%UnchangedHolders
Q2 2021232,672$45.6M0.4%+3,633+1.6%AddedHolders
Q1 2021229,039$41.5M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.